Regulation of caspase activation in apoptosis: Implications in pathogenesis and treatment of disease

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 4, 1999, Pages 295-303

  Kumar, Sharad ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Apaf 1; Bcl 2; Caspase inhibitors; Caspases; CED 3; CED 4; CED 9; Cell death

Indexed keywords

CASPASE; CASPASE INHIBITOR; INTERLEUKIN 1BETA; PROTEIN BCL 2;

APOPTOSIS; CAENORHABDITIS ELEGANS; CELL DEATH; ENZYME ACTIVATION; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; NONHUMAN; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CAENORHABDITIS ELEGANS; CASPASES; DEOXYRIBONUCLEASES; ENZYME ACTIVATION; FEMALE; HUMANS; HUNTINGTON DISEASE; MICE;

EID: 0032927581     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03031.x     Document Type: Review

References (99)

1. 1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-57.
2. 2. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-6.
3. 3. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097-9.
4. H on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899-906.
5. 5. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-2.
6. 6. Adams JM, Cory S. The Bcxl-2 protein family: Arbiters of cell survival. Science 1998; 281: 1322-6.
7. 7. Strasser A, Huang DCS, Vaux DL. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control in tumorigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1997; 1333: F151-78.
8. 8. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-5.
9. 9. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
10. 10. Hetts SW. To die or not to die: An overview of apoptosis and its role in disease. JAMA 1998; 279: 300-7.
11. 11. Roy N, Mahadevan MS, McLean M et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80: 167-78.
12. 12. Hengartner MO. Cell death. In: Riddle DL, Blumanthal T, Meyer BJ, Priess JR (eds). C. elegans II. Cold Spring Harbor Laboratory Press, Plainview, NY. 1997; 383-415.
13. 13. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1993; 258: 1955-7.
14. 14. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homologue of the mammalian proto-oncogene bcl-2. Cell 1994; 76: 665-76.
15. 15. Yuan J, Shaham S, Ledoux S, Ellis H, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993; 75: 641-52.
16. 16. Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992; 356: 768-74.
17. 17. Kumar S, Tomooka Y, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Commun. 1992; 185: 1155-61.
18. 18. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome C-dependent activation of caspase-3. Cell 1997; 90: 405-13.
19. 19. Conradt B, Horvitz HR. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 1998; 93: 519-29.
20. 20. Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem. Sci. 1997; 22: 299-306.
21. 21. Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998; 12: 1551-70.
22. 22. Humke EW, Ni J, Dixit VM. ERICE, a novel FLICE-activatable caspase. J. Biol. Chem. 1998; 273: 15 702-7.
23. 23. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1β converting enzyme. Genes Dev. 1994; 8: 1613-26.
24. 24. Li P, Allen H, Banerjee S et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxin shock. Cell 1995; 80: 401-11.
25. 25. Kuida K, Lippke JA, Ku G et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1beta converting enzyme. Science 1995; 267: 2000-3.
26. 26. Wang S, Miura M, Bergeron L, Zhu H, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-9.
27. 27. Bergeron L, Perez GI, Macdonald G et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 1998; 12: 1304-14.
28. 28. Kuida K, Zheng TS, Na S et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-72.
29. 29. Woo M, Hakem R, Soengas MS et al. Essential contribution of caspase-3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 1998; 12: 806-19.
30. 30. Kuida K, Haydar TF, Kuan C-Y et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325-37.
31. 31. Hakem R, Hakem A, Duncan GS et al. Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell 1998; 94: 339-52.
32. 32. Varfolomeev EE, Schuchmann M, Luria V et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9: 267-76.
33. 33. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel Mort1/FADD-interacting protease, in Fas/APO1-and TNF receptor-induced cell death. Cell 1996; 85: 803-15.
34. 34. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex (DISC). Cell 1996; 85: 817-27.
35. 35. Medema JP, Scaffidi C, Kischkel FC et al. FLICE as activated by association with the CD95 death-inducing signalling complex (DISC). EMBO J. 1997; 16: 2794-804.
36. 36. Vincenz C, Dixit VM. Fas associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signalling. J. Biol. Chem. 1997; 272: 6578-83.
37. 37. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997; 385: 86-90.
38. 38. Butt AJ, Harvey NL, Parasivam G, Kumar S. Dimerisation and auto-processing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl terminal regions. J. Biol. Chem. 1998; 273: 6763-8.
39. 39. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J. Biol. Chem. 1998; 273: 2926-30.
40. 40. Yang X, Chang HY, Baltimore D. Autoproteolytic activation of procaspases by oligomerization. Mol. Cell 1998; 1: 319-25.
41. 41. Colussi PA, Harvey NL, Shearwin-Whyatt LM, Kumar S. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J. Biol. Chem. 1998; 273: 26566-70.
42. 42. Shaham S, Horvitz HR. Developing Caenorhabditis elegans neurons may contain both cell death protective and killer activities. Genes Dev. 1996; 10: 578-91.
43. 43. Newton K, Strasser A. The Bcl-2 family and cell death regulation. Curr. Opin. Genet. Dev. 1998; 8: 68-75.
44. 44. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 1997; 275: 1122-6.
45. L, and Apaf-1 form a ternary complex. J. Biol. Chem. 1998; 273: 5841-5.
46. L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl Acad. Sci. USA 1998; 95: 4386-91.
47. 47. Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates the apoptotic protease cascade. Cell 1997; 91: 479-89.
48. 48. Yang J, Liu X, Bhalla K et al. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
49. 49. Pan G, Humke EW, Dixit VM. Activation of caspases triggered by cytochrome c in vitro. FEBS Lett. 1998; 426: 151-4.
50. 50. Yoshida H, Kong YY, Yoshida R et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998; 94: 739-50.
51. 51. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94: 727-37.
52. 52. Scaffidi C, Fulda S, Srinivasan A et al. Two CD95 (APO-1/Fas) signalling pathways. EMBO J. 1998; 17: 1675-87.
53. 53. Bossay-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 1998; 17: 37-49.
54. 54. Bump NJ, Hackett M, Hugunin M et al. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 1995; 269: 1885-8.
55. 55. Xue D, Horvitz, HR. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 1995; 377: 248-51.
56. 56. Thome M, Schneider P, Hofmann K et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517-21.
57. 57. Irmler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-5.
58. 58. Shu HB, Halpin DR, Goeddel DV. Casper is a FADD-and caspase-related inducer of apoptosis. Immunity 1997; 6: 751-63.
59. 59. Srinivasula SM, Ahmad M, Ottilie S et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 1997; 272: 18542-5.
60. 60. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 1997; 272: 19641-5.
61. 61. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis. J. Biol. Chem. 1997; 272: 17255-7.
62. L and initiates cell death. Proc. Natl Acad. Sci. USA 1997; 94: 11333-8.
63. 63. Rasper DM, Vaillancourt JP, Hadano S et al. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Diff. 1998; 5: 271-88.
64. 64. Liston P, Roy N, Tamai K et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996; 379: 349-53.
65. 65. Duckett CS, Nava VE, Gedrich RW et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 1996; 15: 2685-94.
66. 66. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. Cloning and expression of apoptosis inhibitory protein homologues that function to inhibit apoptosis and/or bind TRAFs. Proc. Natl Acad. Sci. USA 1996; 93: 4974-8.
67. 67. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signalling complex contains two novel proteins related to baculovirus inhibitor of apoptosis proteins. Cell 1995; 83: 1243-52.
68. 68. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 1997; 3: 917-21.
69. 69. Deveraux QL, Takahashi R, Salvasen GS, Reed JC. X-linked IAP is a direct inhibitor of cell death proteases. Nature 1997; 388: 301-4.
70. 70. Vucic D, Kaiser WJ, Miller LK. Inhibitor of apoptosis proteins physically interact with and block apoptosis induced by Drosophila proteins HID and GRIM. Mol. Cell. Biol. 1998; 18: 3300-9.
71. 71. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
72. 72. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-84.
73. 73. Jänicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998; 273: 9357-60.
74. 74. Cheng EHY, Kirsch DG, Clem RJ et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278: 1966-8.
75. L through caspase interaction. Proc. Natl Acad. Sci. USA 1998; 95: 554-9.
76. 76. Kothakota S, Azuma T, Reinhard C et al. Caspase-3 generated fragment of gelsolin: Effector of morphological changes in apoptosis. Science 1997; 278: 294-8.
77. 77. Rudel T, Bokoch G. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997; 276: 1571-4.
78. 78. Lu CD, Altieri DC, Tanigawa N. Expression of novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998; 58: 1808-12.
79. 79. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. Anti-apoptosis gene, surviving, and prognosis of neuroblastoma. Lancet 1998; 351: 882-3.
80. 80. Goldberg YP, Nicholson DW, Rasper DM et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 1996; 13: 442-9.
81. 81. Milligan CE, Prevette D, Yaginuma H et al. Peptide inhibitors of the ICE-like protease family arrest programmed cell death of motorneurons in vivo and in vitro. Neuron 1995; 15: 385-93.
82. 82. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tetrapeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 1996; 184: 2067-72.
83. 83. Roquet N, Pages J-C, Molina T, Briand P, Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. Biol. 1996; 6: 1192-5.
84. 84. Kunstle G, Leist M, Uhlig S et al. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol. Lett. 1997; 55: 5-10.
85. 85. Perez GI, Knudson CM, Leykin L, Korsmeyer SJ, Tilly JL. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nature Med. 1997; 3: 1228-32.
86. 86. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/ reperfusion injury in rats by caspase inhibitor. Circulation 1998; 27: 276-81.
87. 87. Loddick SA, MacKenzie A, Rothwell NJ. An TCE inhibitor, z-VED-DCB attenuates ischaemic brain damage in the rat. Neuroreport 1996; 7: 1465-8.
88. 88. Hara H, Friedlander RM, Gagliardini V et al. Inhibition of interleukin 1-beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl Acad. Sci. USA 1997; 94: 2007-12.
89. 89. Barinaga M. Stroke-damaged neurons may commit cellular suicide. Science 1998; 281: 1302-3.
90. 90. Xu DG, Crocker SJ, Doucet JP et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med. 1997; 3: 997-1004.
91. 91. Davidson FF, Steller H. Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants. Nature 1998; 391: 587-91.
92. 92. Friedlander RM, Brown RH, Gagliardini V, Wang J, Yuan J. Inhibition of ICE slows ALS in mice. Nature 1997; 388: 31.
93. 93. Friedlander RM, Gagliardini V, Hara H et al. Expression of a dominant negative mutant of interleukin-1β converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 1997; 185: 933-40.
94. 94. MacCorkle RA, Freeman KW, Spencer DM. Synthetic activation of caspases: Artificial death switches. Proc. Natl Acad. Sci. USA 1998; 95: 3655-60.
95. 95. Sheridan JP, Marsters SA, Pitti RM et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277: 818-21.
96. 96. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997; 277: 815-18.
97. 97. Van de Craen M, Vandenabeele P, Declercq W et al. Characterization of seven murine caspase family members. FEBS Lett. 1997; 403: 61-9.
98. 98. Talanian RV, Quinlan C, Trautz S et al. Substrate specificities of caspase family proteases. J. Biol. Chem. 1977; 272: 9677-82.
99. 99. Thornberry NA, Rano TA, Peterson EP et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 1977; 272: 17907-11.